Shortening the paths to type 1 diabetes mellitus prevention

Nat Rev Endocrinol. 2021 Feb;17(2):73-74. doi: 10.1038/s41574-020-00450-5.
No abstract available

Publication types

  • Review

MeSH terms

  • Administration, Oral
  • Asymptomatic Diseases / therapy
  • Autoantibodies / immunology
  • Diabetes Mellitus, Type 1 / diagnosis
  • Diabetes Mellitus, Type 1 / immunology
  • Diabetes Mellitus, Type 1 / prevention & control*
  • Disease Progression
  • Humans
  • Hypoglycemic Agents / administration & dosage*
  • Immunologic Memory / immunology
  • Insulin / administration & dosage
  • Interleukin-2 / therapeutic use*
  • Mass Screening
  • Receptors, Interleukin-7 / antagonists & inhibitors*
  • T-Lymphocyte Subsets / immunology
  • T-Lymphocytes, Regulatory / immunology

Substances

  • Autoantibodies
  • Hypoglycemic Agents
  • Insulin
  • Interleukin-2
  • Receptors, Interleukin-7